Mitja did his PhD in collaboration with Novartis on the topic of protein aggregation and degradation. He is situated in the Structure-Biophysics-Stability group in Novartis, working on the interface of developability assessment and early technical development of biologics, combining experimental, computational, and modelling techniques on a daily basis.